You have 9 free searches left this month | for more free features.

NTRK3

Showing 26 - 50 of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity, Child Trial (sequencing of a panel of 14 genes in leptin melanocortin pathway)

Not yet recruiting
  • Obesity, Child
  • sequencing of a panel of 14 genes in leptin melanocortin pathway
  • (no location specified)
Jul 3, 2023

Cervical/Supraclavicular Metastasis From Non-small-cell Lung

Recruiting
  • Lung Cancer Metastatic
  • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
  • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)

No longer available
  • Cancers With NTRK, ROS1, or ALK Gene Fusions
  • San Diego, California
    1-844-Startrk (782-7875)
Apr 24, 2019

NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

Not yet recruiting
  • NSCLC Stage IV
  • +4 more
  • Nivolumab and Ipilimumab
  • Verona, Veneto/Verona, Italy
    Centro Ricerche Cliniche
Oct 26, 2022

NSCLC Trial in United States (Alectinib, Entrectinib, Vemurafenib)

Recruiting
  • Non-small Cell Lung Cancer
  • Duarte, California
  • +24 more
Feb 2, 2023

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Trial in Shanghai (SIM1803-1A)

Recruiting
  • Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
  • Shanghai, China
    Shanghai Chest Hospital
Jan 11, 2021

Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic NSCLC Trial in Beijing (XZP-5955 tablets)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Locally Advanced or Metastatic Non-small Cell Lung Cancer
  • XZP-5955 tablets
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
May 17, 2022

Advanced Solid Tumor Trial in Changsha (IBI363)

Not yet recruiting
  • Advanced Solid Tumor
  • Changsha, Hunan, China
    Yongchang Zhang
Oct 12, 2023

Cancer (With or Without Metastasis) Trial in Houston (TSN084)

Recruiting
  • Cancer (With or Without Metastasis)
  • Houston, Texas
    MD Anderson Cancer Center
Apr 22, 2022

Lung Cancer Trial in Angers, St Herblain (Metastasis biopsy)

Not yet recruiting
  • Lung Cancer
  • Metastasis biopsy
  • Angers, France
  • +1 more
Jul 26, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic

Recruiting
  • Non Small Cell Lung Cancer
    • Los Angeles, California
    • +5 more
    Jun 9, 2022

    Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +30 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +123 more
    Aug 23, 2022

    Metastasis, Tumor Trial in HangZhou (BPI-28592)

    Recruiting
    • Metastasis, Neoplasm
    • HangZhou, Zhejiang, China
      Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
    Mar 21, 2022

    Solid Tumors Trial in United States (DS6051b)

    Completed
    • Solid Tumors
    • Scottsdale, Arizona
    • +5 more
    Sep 18, 2020

    NSCLC Trial in United States

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Daphne, Alabama
      • +17 more
      Nov 30, 2022

      Post Traumatic Stress Disorder, Complex PTSD, Stress Trial in Palo Alto, San Juan (Start with the Heart Students, Start with the

      Not yet recruiting
      • Post Traumatic Stress Disorder
      • +4 more
      • Start with the Heart Students
      • +4 more
      • Palo Alto, California
      • +1 more
      Jan 24, 2023

      NSCLC Trial in United States

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
        • Daphne, Alabama
        • +16 more
        May 30, 2023

        Tumors Harboring NTRK Fusion Trial (Larotrectinib (Vitrakvi, BAY2757556))

        Approved for marketing
        • Tumors Harboring NTRK Fusion
        • Larotrectinib (Vitrakvi, BAY2757556)
        • (no location specified)
        Dec 18, 2019

        Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

        Recruiting
        • Lymphoma, Non-Hodgkin
        • +2 more
        • Birmingham, Alabama
        • +125 more
        Nov 21, 2022

        Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +49 more
        • Birmingham, Alabama
        • +1429 more
        Aug 17, 2022

        Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

        Recruiting
        • Advanced Cancer
        • Solid Tumor
        • Helsinki, Uusimaa, Finland
        • +2 more
        Jun 8, 2022

        Digital Support of Patients With Inoperable Lung Cancer

        Recruiting
        • Non-Small Cell Carcinoma of Lung, TNM Stage 4
        • Digital platform
        • Psychikó, Attiki, Greece
        • +14 more
        May 12, 2022